Annual accounts
Total Exemption Full accounts
30/06/2027Filing deadline
- Next accounts made up to
- 30/09/2026
- Last accounts made up to
- 30/09/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Appointment of Mrs Asha Din as a director on 2026-02-18
Appointment of Mr Mohammad Gias Din as a director on 2026-02-16
Termination of appointment of Robert Terence Smith as a director on 2026-02-16
Termination of appointment of Satish Kumar Narang as a director on 2026-02-16
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
30/06/2027Filing deadline
Confirms the registry record is up to date
14/10/2026Filing deadline
The latest figures SUNRISE PHARMA LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £-28.89K
Total Assets
2024: £456.87K
Cash in Bank
2024: £96.59K
Total Liabilities
2024: £485.76K
Employees
2024: 6
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Total liabilities moved furthest, down 99.83% on 2024. See the full financial analysis for SUNRISE PHARMA LIMITED.
The full financial record
Four ways through SUNRISE PHARMA LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 6 | 0 |
| 2024 | 6 | 0 |
| 2023 | 6 | -1 |
| 2022 | 7 | +1 |
| 2021 | 6 | – |
Reported employee count was unchanged at 6 between 2021 and 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 14/09/2021–16/02/2026 | 13 | |
| Director | 30/09/2010–18/12/2015 | 3 | |
| Director | 31/05/2017–16/02/2026 | 3 | |
| Director | 18/12/2015–31/07/2020 | 13 | |
| Director | 18/02/2026–Present | 2 | |
| Director | 16/02/2026–Present | 2 | |
| Director | 10/12/2010–14/12/2021 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–Present | 13 | |
| 06/04/2016–16/02/2026 | 13 | |
| 16/02/2026–Present | 0 |
Every document on the Companies House record, newest first.
Appointment of Mrs Asha Din as a director on 2026-02-18
Appointment of Mr Mohammad Gias Din as a director on 2026-02-16
Termination of appointment of Robert Terence Smith as a director on 2026-02-16
Termination of appointment of Satish Kumar Narang as a director on 2026-02-16
Notification of Din Healthcare Limited as a person with significant control on 2026-02-16
Cessation of Satish Kumar Narang as a person with significant control on 2026-02-16
Registered office address changed from 24 Roundbush Crescent Caerwent Monmouthshire NP26 5AG to 226 Sandy Lane Droylsden Manchester M43 7JX on 2026-02-18
Registration of charge 073931550002, created on 2026-02-16
Registration of charge 073931550003, created on 2026-02-16
Registration of charge 073931550004, created on 2026-02-16
Total exemption full accounts made up to 2025-09-30
Confirmation statement made on 2025-09-30 with no updates
Showing 12 of 17 filings
See when the next accounts and confirmation statement are due
2,567 UK companies are similar to SUNRISE PHARMA LIMITED, sharing the same company status (Active), the same industry sector and activity group (Dispensing chemist in specialised stores) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
Suite 9 Pine Court Business Centre, 36 Gervis Road, Bournemouth BH1 3DH
Unit 23 Block 4 Britannia House, Brignell Road, Middlesbrough TS2 1PS
6 Raleigh Road, Southall, Middlesex UB2 5TW
25 St Thomas Street, Winchester, Hampshire SO23 9HJ
Unit 1, 81 Dargan Road, Belfast BT3 9JU
A short description of the company, written from its Companies House record.
SUNRISE PHARMA LIMITED is a private limited company registered in the United Kingdom, based in 226 Sandy Lane, Droylsden, Manchester M43 7JX. Companies House classifies its business as Dispensing chemist in specialised stores. It has been on the register for 16 years.
The register currently records it as active. Its 2025 accounts report net assets of £24.78K and 6 employees.
Answered from this company's own registry record and filed figures.
Companies House records SUNRISE PHARMA LIMITED under one registered business activity: Dispensing chemist in specialised stores (47.73 - SIC 2007).
SUNRISE PHARMA LIMITED is recorded as active on the Companies House register, and has been on it since 30/09/2010.
The most recent accounts Okredo holds cover 2025 and report net assets of £24.78K, total assets of £125.97K, cash in bank of £172.90K and total liabilities of £818.00.
The most recent document on the record is dated 26/02/2026: Appointment of Mrs Asha Din as a director on 2026-02-18, 7 months ago.
On the current registry record, accounts are due by 30/06/2027 and the next confirmation statement is due by 14/10/2026.
Companies House lists 7 officers (2 currently in post) and 3 people with significant control (2 current).